Verrica Pharmaceuticals to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026
Go back to Verrica Pharmaceuticals to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026| (NASDAQ: VRCA) | Delayed: 5.30 -0.06 (1.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.36 | 52 Week High | $ | |||
| Open | $5.28 | 52 Week Low | $ | |||
| Day High | $5.53 | P/E | N/A | |||
| Day Low | $5.25 | EPS | $ | |||
| Volume | 12,198 | |||||

